LAM Centre Celebrates 10 Years at Nottingham University Hospitals
This year, The National Centre for Lymphangioleiomyomatosis (LAM) celebrates its 10 year anniversary. In 2011, the Nottingham LAM group...
top of page
Search
Glenn Hearson
- May 24, 2021
More positive results from #ANDHI study for Benralizumab in Severe Eosinophilic Asthma
The #ANDHI study, has recently had more results published in the European Journal of Allergy and Clinical Immunology "Benralizumab...
65
Glenn Hearson
- Apr 1, 2021
Nottingham Asthma Centre Newsletter: Spring 2021
The Spring 2021 Asthma Newsletter is now out.
49
Glenn Hearson
- Mar 24, 2021
A year ago today NUH recruited their 1st patient into the worlds biggest #Covid19 treatment trial
It was one year ago today that Nottingham University Hospitals, using teams including those from the NIHR Nottingham BRC and...
80
Glenn Hearson
- Jan 2, 2021
Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
140
Glenn Hearson
- Nov 17, 2020
APEX Asthma Exacerbation Studies Newsletter
Our APEX research studies looking into asthma attacks (exacerbations) new newsletter is now available. The APEX Studies are investigating...
66
Glenn Hearson
- Nov 9, 2020
PONENTE study hits the mark in phase IIIb asthma trial
PONENTE Phase IIIb open-label Fasenra (benralizumab)
110
Glenn Hearson
- Oct 5, 2020
The Nottingham Recovery from COVID-19 Research Platform Assessment Clinic
The Nottingham Recovery from COVID-19 Research Platform Assessment Clinic
292
bottom of page